Application of Carquinostatin A compound in preparation of medicine for treating inflammatory bowel disease

The invention discloses an application of a CarquinostatinA compound or a pharmaceutical salt thereof in preparation of a medicine for treating inflammatory bowel diseases. The structure of the CarquinostatinA compound is shown in the specification. The CarquinostatinA compound disclosed by the invention has a remarkable treatment effect on the inflammatory bowel diseases as a small molecule compound, and has the characteristics of low toxicity and remarkable curative effect. Therefore, the CarquinostatinA compound can be used as a lead compound of a major disease, i.e., the inflammatory bowel disease, has important development prospects and clinical application values, and also provides a scientific basis for further exploring an IBD pathogenesis mechanism. 本发明公开了一种CarquinostatinA化合物或其药用盐在制备治疗炎症性肠病的药物中的应用，所述CarquinostatinA化合物的结构如下所示：本发明的CarquinostatinA化合物作为小分子化合物对炎症性肠病具有显著的治疗作用，具有毒性低，疗效显著的特征。因此，CarquinostatinA化合物可作为炎症性肠病这一重大疾病的先导化合物，具有重要的开发前景和临床应用价值，也为进一步探究IBD发病的机制，提供了科学依据。